Detalhe da pesquisa
1.
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Proc Natl Acad Sci U S A
; 121(17): e2321898121, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625939
2.
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Proc Natl Acad Sci U S A
; 118(15)2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876771
3.
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma.
Int J Cancer
; 151(4): 637-648, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429348
4.
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
Proc Natl Acad Sci U S A
; 116(2): 619-624, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30584090
5.
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Proc Natl Acad Sci U S A
; 116(45): 22730-22736, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624127
6.
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
BMC Cancer
; 21(1): 561, 2021 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001010
7.
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.
Int J Cancer
; 147(2): 565-574, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096871
8.
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.
Br J Cancer
; 121(7): 584-592, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434988
9.
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Proc Natl Acad Sci U S A
; 113(43): 12238-12243, 2016 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27791010
10.
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Br J Cancer
; 117(4): 494-502, 2017 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664915
11.
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.
BMC Cancer
; 17(1): 366, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28545541
12.
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.
Gynecol Oncol
; 144(1): 146-152, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27894751
13.
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
J Cell Mol Med
; 20(12): 2341-2348, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27419385
14.
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.
Gynecol Oncol
; 141(2): 303-311, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26801941
15.
Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy.
Int J Gynecol Cancer
; 26(1): 52-5, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512790
16.
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
Proc Natl Acad Sci U S A
; 110(8): 2916-21, 2013 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359684
17.
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
Proteomics
; 15(2-3): 365-73, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311472
18.
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
J Transl Med
; 11: 162, 2013 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23819652
19.
Class III ß-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
Am J Obstet Gynecol
; 209(1): 62.e1-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23583215
20.
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.
Clin Chem Lab Med
; 51(9): 1815-24, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24013103